All In MedTech

Device Trial Radar · NCT07195708

Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')

Clinical Study to Evaluate the Safety and Efficacy of the Orbera365 Intragastric Balloon System in Obese Patients

Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 144 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

144

Planned (sponsor's estimate)

Start

Jun 3, 2026

Primary completion

Jun 30, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Sep 29, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate the safety and efficacy of Orbera365 in obese populations to support the registration of Orbera365.

Conditions

  • Weight Loss

Interventions

  • Treatment groupDevice

    The treatment group was the group with the placement of Orbera 365 plus lifestyle management

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. %TBWL (Defined as the percentage of total body weight loss)Time frame: At 12 months after the intervention
  2. The response rate at the 12th month after the interventionTime frame: At 12 months after the intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Changhai Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.